Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

VEGFA Antikörper

Dieser Maus Monoklonal Antikörper detektiert spezifisch VEGFA in WB, ELISA und Func. Es zeigt Reaktivität gegenüber Proben von Human.
Produktnummer ABIN2745578
628,08 €
Zzgl. Versandkosten 20,00 € und MwSt
200 μg
Lieferung nach: Deutschland
Lieferung in 2 bis 5 Werktagen

Kurzübersicht für VEGFA Antikörper (ABIN2745578)

Target

Alle VEGFA Antikörper anzeigen
VEGFA (Vascular Endothelial Growth Factor A (VEGFA))

Reaktivität

  • 254
  • 124
  • 122
  • 25
  • 23
  • 19
  • 8
  • 6
  • 5
  • 5
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Human

Wirt

  • 254
  • 88
  • 15
  • 12
  • 2
  • 2
  • 1
Maus

Klonalität

  • 257
  • 112
  • 3
Monoklonal

Konjugat

  • 179
  • 47
  • 27
  • 15
  • 12
  • 11
  • 8
  • 5
  • 5
  • 5
  • 5
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser VEGFA Antikörper ist unkonjugiert

Applikation

  • 216
  • 94
  • 92
  • 54
  • 41
  • 41
  • 30
  • 25
  • 24
  • 24
  • 16
  • 10
  • 10
  • 9
  • 7
  • 7
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Functional Studies (Func)

Klon

3(6D3)
  • Verwendungszweck

    anti-VEGF-A (human), mAb (3(6D3))

    Produktmerkmale

    Monoclonal Antibody. Isotype: Mouse IgG1. Clone: 3(6D3). Applications: ELISA, FUNC, WB. Lyophilized. Human vascular endothelial erowth factor (VEGF 165) is produced as a homodimer. It binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin. VEGF-A is a specific mitogen for vascular endothelial cells and a strong angiogenic factor in vivo. In addition to its action as a mitogen it is a potent vascular permeability factor (VPF) in vivo. It is also a chemoattractant molecule for monocytes and endothelial cells. It induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels.

    Aufreinigung

    Protein G purified.

    Immunogen

    Recombinant human VEGF 165.

    Isotyp

    IgG1
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Centrifuge vial prior to opening. Reconstitute with sterile water to a concentration of 0.1-1.0 mg/mL.

    Buffer

    Lyophilized from a buffer containing Trehalose, Na-Phosphate and Polysorbat 20.

    Handhabung

    After opening, prepare aliquots and store at -20 °C.Avoid freeze/thaw cycles.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    +4°C

    -20°C

    Stable for at least 6 months after receipt when stored at -20°C.

    Haltbarkeit

    6 months
  • Target

    VEGFA (Vascular Endothelial Growth Factor A (VEGFA))

    Andere Bezeichnung

    VEGF-A

    Hintergrund

    Alternate Names/Synonyms: Vascular Endothelial Growth Factor-A, VPF

    Product Description: Human vascular endothelial growth factor (VEGF 165) is produced as a homodimer. It binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin. VEGF-A is a specific mitogen for vascular endothelial cells and a strong angiogenic factor in vivo. In addition to its action as a mitogen it is a potent vascular permeability factor (VPF) in vivo. It is also a chemoattractant molecule for monocytes and endothelial cells. It induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels.

    UniProt

    P15692

    Pathways

    RTK Signalweg, Glycosaminoglycan Metabolic Process, Regulation of Cell Size, Tube Formation, Signaling Events mediated by VEGFR1 and VEGFR2, Platelet-derived growth Factor Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling
Sie sind hier:
Chat with us!